Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Scilex Holding Co. (SCLX)

Scilex Holding Co. (SCLX)
0.1964 x 10 0.2100 x 100
Pre-market by (Cboe BZX)
0.1961 -0.0538 (-21.53%) 04/11/25 [NASDAQ]
0.1964 x 10 0.2100 x 100
Pre-market 0.1966 +0.0005 (+0.25%) 07:17 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.1800
Day High
0.2095
Open 0.1992
Previous Close 0.2499 0.2499
Volume 5,122,000 5,122,000
Avg Vol 1,395,005 1,395,005
Stochastic %K 16.53% 16.53%
Weighted Alpha -89.31 -89.31
5-Day Change -0.0620 (-24.02%) -0.0620 (-24.02%)
52-Week Range 0.1800 - 2.3000 0.1800 - 2.3000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,714
  • Shares Outstanding, K 243,313
  • Annual Sales, $ 56,590 K
  • Annual Income, $ -72,810 K
  • EBIT $ -79 M
  • EBITDA $ -75 M
  • 60-Month Beta 1.04
  • Price/Sales 1.07
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.62
  • Most Recent Earnings $-0.18 on 01/17/25
  • Next Earnings Date 05/12/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 441.66% ( +135.77%)
  • Historical Volatility 134.84%
  • IV Percentile 94%
  • IV Rank 61.40%
  • IV High 701.38% on 01/03/25
  • IV Low 28.60% on 10/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 91
  • Volume Avg (30-Day) 108
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 5,082
  • Open Int (30-Day) 5,950

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.12
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +65.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1800 +8.94%
on 04/11/25
Period Open: 0.3215
0.3400 -42.32%
on 03/19/25
-0.1254 (-39.00%)
since 03/11/25
3-Month
0.1800 +8.94%
on 04/11/25
Period Open: 0.4546
0.5250 -62.65%
on 01/16/25
-0.2585 (-56.86%)
since 01/10/25
52-Week
0.1800 +8.94%
on 04/11/25
Period Open: 1.3000
2.3000 -91.47%
on 06/17/24
-1.1039 (-84.92%)
since 04/11/24

Most Recent Stories

More News
Scilex Holding Company Announces 1-for-35 Reverse Stock Split

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28,...

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Announces that It Will Be Filing Today of a Supplemental New Drug Application with the FDA for ELYXYB® in Acute Pain Indication

SCLX : 0.1961 (-21.53%)
Scilex Holding Company Announces Filing of its Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2024

SCLX : 0.1961 (-21.53%)

Business Summary

Scilex Holding Company is a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain. Scilex Holding Company, formerly known as Vickers Vantage Corp. I, is based in PALO ALTO, Calif.

See More

Key Turning Points

3rd Resistance Point 0.2399
2nd Resistance Point 0.2247
1st Resistance Point 0.2104
Last Price 0.1961
1st Support Level 0.1809
2nd Support Level 0.1657
3rd Support Level 0.1514

See More

52-Week High 2.3000
Fibonacci 61.8% 1.4902
Fibonacci 50% 1.2400
Fibonacci 38.2% 0.9898
Last Price 0.1961
52-Week Low 0.1800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar